- Professor Ojima
- Research
- Research Overview
- Next-Generation Pain Control with Novel Stony Brook Fatty Acid Binding Protein (FABP) Inhibitors (SB-Fls)
- FABP Inhibitors (SB-FIs) as New-Generation Anticancer Agents
- Acylhydrazones as Novel Antifungal Agents
- Sterylglucosidases Inhibitor As Novel Antifungal Agents
- Next-Generation Taxoids As Potent And Efficacious Anticancer Agents
- Tumor-Targeted Delivery of Highly Potent Taxoid Anticancer Agents
- Group Members
- News Archives
- Alumni
- Photo Gallery
- Contact Us
- More
- HOME
- Professor Ojima
- Research
- Research Overview
- Next-Generation Pain Control with Novel Stony Brook Fatty Acid Binding Protein (FABP) Inhibitors (SB-Fls)
- FABP Inhibitors (SB-FIs) as New-Generation Anticancer Agents
- Acylhydrazones as Novel Antifungal Agents
- Sterylglucosidases Inhibitor As Novel Antifungal Agents
- Next-Generation Taxoids As Potent And Efficacious Anticancer Agents
- Tumor-Targeted Delivery of Highly Potent Taxoid Anticancer Agents
- Group Members
- News Archives
- Alumni
- Photo Gallery
- Contact Us
- More
